163 related articles for article (PubMed ID: 21074271)
1. Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.
Culpepper DJ; Maddox MK; Caldwell AB; McFarland BJ
Mol Immunol; 2011 Jan; 48(4):516-23. PubMed ID: 21074271
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic core evolution of major histocompatibility complex class I chain-related protein A for dramatic enhancing binding affinity.
Cai W; Peng S; Tian Y; Bao Y; Liu Q; Dong Y; Liang Z; Liu Q; Ren Y; Ding P; Liu J; Xu T; Li Y
Int J Biol Macromol; 2024 Jun; 271(Pt 2):132588. PubMed ID: 38788878
[TBL] [Abstract][Full Text] [Related]
3. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.
Müller S; Zocher G; Steinle A; Stehle T
PLoS Pathog; 2010 Jan; 6(1):e1000723. PubMed ID: 20090832
[TBL] [Abstract][Full Text] [Related]
4. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
[TBL] [Abstract][Full Text] [Related]
5. NKG2D discriminates diverse ligands through selectively mechano-regulated ligand conformational changes.
Fan J; Shi J; Zhang Y; Liu J; An C; Zhu H; Wu P; Hu W; Qin R; Yao D; Shou X; Xu Y; Tong Z; Wen X; Xu J; Zhang J; Fang W; Lou J; Yin W; Chen W
EMBO J; 2022 Dec; 41(2):e107739. PubMed ID: 34913508
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
[TBL] [Abstract][Full Text] [Related]
7. A disease-linked
Zuo J; Willcox CR; Mohammed F; Davey M; Hunter S; Khan K; Antoun A; Katakia P; Croudace J; Inman C; Parry H; Briggs D; Malladi R; Willcox BE; Moss P
Sci Signal; 2017 May; 10(481):. PubMed ID: 28559451
[TBL] [Abstract][Full Text] [Related]
8. Mutations designed to destabilize the receptor-bound conformation increase MICA-NKG2D association rate and affinity.
Lengyel CS; Willis LJ; Mann P; Baker D; Kortemme T; Strong RK; McFarland BJ
J Biol Chem; 2007 Oct; 282(42):30658-66. PubMed ID: 17690100
[TBL] [Abstract][Full Text] [Related]
9. Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.
Gavlovsky PJ; Tonnerre P; Gérard N; Nedellec S; Daman AW; McFarland BJ; Charreau B
J Immunol; 2016 Aug; 197(3):736-46. PubMed ID: 27342847
[TBL] [Abstract][Full Text] [Related]
10. Combining different design strategies for rational affinity maturation of the MICA-NKG2D interface.
Henager SH; Hale MA; Maurice NJ; Dunnington EC; Swanson CJ; Peterson MJ; Ban JJ; Culpepper DJ; Davies LD; Sanders LK; McFarland BJ
Protein Sci; 2012 Sep; 21(9):1396-402. PubMed ID: 22761154
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
Front Immunol; 2018; 9():1282. PubMed ID: 29963042
[TBL] [Abstract][Full Text] [Related]
12. Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
Machuldova A; Holubova M; Caputo VS; Cedikova M; Jindra P; Houdova L; Pitule P
Front Immunol; 2021; 12():651751. PubMed ID: 33868289
[TBL] [Abstract][Full Text] [Related]
13. Efficient In Vitro Refolding and Characterization of Major Histocompatibility Complex Class I-Related Chain Molecules A (MICA) and Natural Killer Group 2 Member D (NKG2D) Expressed in E. coli.
Zhao X; Acheampong DO; Wang Y; Tang M; Xie W; Chen Z; Wang M; Zhang J
Protein Pept Lett; 2015; 22(5):460-9. PubMed ID: 25925769
[TBL] [Abstract][Full Text] [Related]
14. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
15. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8
Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F
Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217
[TBL] [Abstract][Full Text] [Related]
16. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():926. PubMed ID: 29765374
[TBL] [Abstract][Full Text] [Related]
17. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
18. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
Kim Y; Born C; Bléry M; Steinle A
Front Immunol; 2020; 11():960. PubMed ID: 32582150
[TBL] [Abstract][Full Text] [Related]
19. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.
Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R
EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398
[TBL] [Abstract][Full Text] [Related]
20. Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation.
Petersdorf EW; McKallor C; Malkki M; He M; Spellman SR; Hsu KC; Strong RK; Gooley T; Stevenson P
Blood Adv; 2023 Jun; 7(12):2888-2896. PubMed ID: 36763517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
